CORD-19:22616110b79baaf4c9d23f130a9ee35c64d991f7 / 46617-46819 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T485","span":{"begin":0,"end":202},"obj":"Sentence"}],"text":"However, low resistance rates are shown for nitrofurantoin and fosfomycin, in both ESBL and not ESBL E. coli, which suggests that these antibiotics may be a good option in the empiric treatment of UTIs."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T485","span":{"begin":0,"end":202},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"However, low resistance rates are shown for nitrofurantoin and fosfomycin, in both ESBL and not ESBL E. coli, which suggests that these antibiotics may be a good option in the empiric treatment of UTIs."}

{"project":"Epistemic_Statements","denotations":[{"id":"T69","span":{"begin":0,"end":202},"obj":"Epistemic_statement"}],"text":"However, low resistance rates are shown for nitrofurantoin and fosfomycin, in both ESBL and not ESBL E. coli, which suggests that these antibiotics may be a good option in the empiric treatment of UTIs."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T234","span":{"begin":197,"end":201},"obj":"Disease"}],"attributes":[{"id":"A234","pred":"mondo_id","subj":"T234","obj":"http://purl.obolibrary.org/obo/MONDO_0001650"}],"text":"However, low resistance rates are shown for nitrofurantoin and fosfomycin, in both ESBL and not ESBL E. coli, which suggests that these antibiotics may be a good option in the empiric treatment of UTIs."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T55","span":{"begin":197,"end":201},"obj":"Phenotype"}],"attributes":[{"id":"A55","pred":"hp_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/HP_0000010"}],"text":"However, low resistance rates are shown for nitrofurantoin and fosfomycin, in both ESBL and not ESBL E. coli, which suggests that these antibiotics may be a good option in the empiric treatment of UTIs."}